Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$210,470
+$111,117 QoQ
Shares Held
36,860
+128.2% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 196 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Derivatives in MYGN
reported options exposure · as of Jun 30, 2023CallValue
$14,464,320
CallShares
624,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $727,123,354 across 18 Diagnostics & Research names. MYGN ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
449,628 | $225,425,494 | |
| 2 | DHR |
Danaher Corp /De/
|
759,207 | $144,613,749 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
700,425 | $135,336,117 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
54,686 | $69,861,911 | |
| 5 | DGX |
Quest Diagnostics Inc
|
275,371 | $58,364,883 | |
| 6 | WAT |
Waters Corp /De/
|
138,443 | $51,921,662 | |
| 7 | GH |
Guardant Health, Inc.
|
124,368 | $18,658,930 | |
| 8 | RVTY |
Revvity, Inc.
|
63,056 | $7,015,610 |
All Filings in MYGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $210,470 | 36,860 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $99,353 | 16,155 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,047,952 | 144,945 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $7,652,920 | 862,787 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,143,167 | 83,382 | Shares | Sole | 2025-02-14 | |
| 2023-09-30 | $4,664,559 | 290,808 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $14,464,320 | 624,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $33,535,548 | 1,446,745 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $12,813,668 | 551,600 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $36,911,934 | 1,588,977 | Shares | Other | 2023-05-15 | |
| 2022-09-30 | $500,754 | 26,245 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $635,949 | 35,000 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $8,090,888 | 321,067 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $7,142,321 | 221,193 | Shares | Sole | 2021-12-01 | |
| 2021-03-31 | $6,503,084 | 213,566 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,519,518 | 532,095 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,562,646 | 196,522 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,662,228 | 146,581 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||